Expression Platform Comparison

Expression Platform Comparison is a systematic evaluation framework within developability assessment that differentiates candidate biotherapeutic expression systems by their ability to produce target molecules with optimal yield, quality, and stability under defined cultivation conditions.

18

Publications

1.2K

Citations

136

Authors

47

Institutions

Publications per year

2017–2026

2

Authors

136

  1. AC
    Aedín C. Culhane

    Dana-Farber Cancer Institute, United States

    2 publications · 161 citations

    2

    h-index

  2. JJ
    John J. Scarcelli

    Pfizer (United States), United States

    1 publications · 48 citations

    1

    h-index

  3. EM
    Eleonora Mangano

    University of Milan, Italy

    1 publications · 42 citations

    1

    h-index

  4. GN
    G. N. Hortobágyi

    The University of Texas MD Anderson Cancer Center, United States

    1 publications · 11 citations

    1

    h-index

  5. OM
    Outi Monni

    University of Helsinki, Finland

    1 publications · 188 citations

    1

    h-index

1–5 of 136

Venues

  1. BMC Genomics

    3 publications · 276 citations

    3

    h-index

  2. PLoS ONE

    2 publications · 64 citations

    2

    h-index

  3. BMC Bioinformatics

    2 publications · 178 citations

    2

    h-index

  4. Journal of Biotechnology

    1 publications · 107 citations

    1

    h-index

  5. Journal of Immunological Methods

    1 publications · 17 citations

    1

    h-index

1–5